Supriya Lifesciences Limited board has approved the appointment of Rajeev Kumar Jain as Chief Executive Officer (CEO) of the company.

He will be joining on October 3, 2022 to take the company on the next phase of its growth journey. He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business.

Dr. Shireesh Ambhaikar, Chief Executive Officer resigned from the position due to his personal reasons and requested, inter alia, for acceptance of his resignation and relieving him by September 30, 2022 and which has been accepted by the board. The board also expressed its gratitude to Dr. Shireesh Ambhaikar for his contribution to the company during his tenure of office and look forward to his continued support and guidance in his new role.

However, Dr. Shireesh Ambhaikar has agreed to extend his services on a retainership basis for a period of two years effective October 1, 2022 where he will be designated as Technical Head for certain projects of Supriya Lifescience Limited to ensure their timely execution, knowledge transfer, and smooth transition to his successor, who will be joining the company on October 3, 2022.